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Abstract
Background: To evaluate ultrasound (US) characteristics and BI-RADS (Breast imaging-reporting and data system) of malignant 
breast masses in women <40 years and to compare with older patients.
Methods: In a retrospective, descriptive-analytical study, we assessed the US images and BI-RADS category of 78 malignant masses 
with a final pathology of invasive ductal carcinoma (IDC, NOS type).
Results: Overall, the most frequent US descriptors of IDC were indistinct margin (45%), irregular shaped (63.5%), posterior 
shadowing (38.8%), heterogeneous internal echogenicity (56.3%) and non-parallel orientation (76.3%). In this study, most 
malignant masses of young patients were categorized as BI-RADS 4a while in the older patients (over 40), they were mostly 
BI-RADS 4b and 5 with P = 0.03 and odds ratio (OR) of 2.57 (95% confidence interval (CI), 0.74–8.8). In addition, the mean 
dimension of the mass in young cases was greater (18.3 mm) compared with older patients (13.2 mm) with P value of 0.04 and 
OR of 3.8 (95% CI, 1.1–13.4). 
Conclusion: Similar to previous studies, malignant masses were diagnosed in greater dimensions in younger cases which may be 
due to the delay in diagnosis, the rapid growth of the tumor and the absence of routine screening guidelines.
Radiologists should be aware of the possibility of malignancy in palpable slightly suspicious masses (BI-RADS 4A) in young cases.
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Breast carcinoma is the most common cancer among 
Iranian women with an estimated rate of 8500 incident 
cases per year which occurs at least one decade younger 
than developed countries.1,2 In recent years and in Asian 
countries, its prevalence has increased.3 This cancer 
has been classified as a significant high prevalence 
disease among Iranian women in the past years.4,5 While 
approximately 7% of all breast cancers occur in young 
females in the USA, such tumors are more aggressive with 
lower survival rate, poor outcome and more accumulated 
lifetime risk of recurrence.6-2
Under the age of 40, mammography is not a routine 
screening modality, and in some studies, it has not been an 
effective modality for detecting breast cancer because of 
the high proportion of thick fibroglandular tissue which 
reduces the diagnostic accuracy.13
Only 1.9% of young patients with breast cancer are 
symptomatic.14 On the other hand, lack of standard 
imaging guidance for screening in younger cases (except 
patients with BRCA mutation) increases the missing of 
non-palpable cancers; some cancers are interpreted as 
benign lesions in different imaging modalities.15
The purpose of this retrospective study is thus to 
determine the US highlights and BI-RADS (Breast 
imaging-reporting and data system) assessment of 
cancerous masses detected by ultrasound (US) in 
younger age groups. We evaluated the margin, shape, size, 
orientation, posterior echo feature, internal echo and final 
BI-RADS assessment of the masses in two age categories. 
These findings would help us detect breast cancer earlier 
on US, especially in young patients.
Material and Methods
In a single institute, the US images of breast masses with a 
final pathology of invasive ductal carcinoma (IDC) NOS-
type between May 2015 and May 2018 were interpreted 
by two expert breast imaging fellow radiologists in 
a retrospective descriptive manner. US images were 
prepared by the Volusan E6 US system. 
According to Breast Cancer Fact and Figures 2017–
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under age 40 is about 4%. So, in this retrospective study 
in Motamed cancer institute, we detected about 39 
patients with invasive cancer and with these inclusion 
criteria: having a mass on US, having pathology of IDC-
NOS (we excluded other pathologies) and not having 
undergone neoadjuvant chemotherapy which changes the 
morphology.
As we know, confounding is a major threat to internal 
validity. There are several methods to modify the 
confounders and in this study, we actively excluded some 
confounders (restriction) such as uncommon types of 
cancer pathology which may affect the shape of the mass 
and patients with history of neoadjuvant pathology. On 
the other hand, we controlled other confounding variables 
such as age by generating groups, additionally all patients 
were female and we excluded men (restriction and 
matching).
Table 1 shows the US features of breast masses.16-19 
Considering the most suspicious findings, we recorded 
the final BI-RADS category. According to BI-RADS atlas 
US lexicon (5th edition), a mass should be seen on two 
planes of US. Oval shaped masses termed as elliptical or 
egg-shaped masses may show two or three undulations. 
Round shape masses have equal anteroposterior and 
transverse diameters. Irregular shaped masses are not 
round or oval.
If the long axis of the mass is parallel to the skin, it is 
named a parallel mass. Otherwise, it is non-parallel. Round 
shaped masses are non-parallel. The most important and 
accurate descriptor is margin.20
A circumscribed mass has an abrupt transition with 
the surrounding tissue. Most of them are round or oval 
in shape. Non-circumscribed masses do not show a sharp 
margin and include indistinct, angular, microlobulated, 
or spiculated masses. Microlobulated masses demonstrate 
over three undulations. Spiculated masses shows lines that 
radiate from the periphery of the mass. Angular masses 
show some sharp acute corners.
The echogenicity of the mass is subdivided into six 
categories including anechoic, hyperechoic, complex, 
isoechoic, heterogeneous or hypoechoic. 
Posterior echo changes have a secondary rather than 
a primary predictive value and they correspond to the 
attenuation or enhancement of the acoustic transmission 
posterior to the lesion. They include no posterior feature, 
shadowing, enhancement, or combined pattern (more 
than one posterior feature).
According to the BI-RADS US lexicon, if a mass does 
not show parallel orientation, no posterior echo change, 
oval or circumscribed mass, it should be categorized as BI-
RADS 4 category with the likelihood of cancer over 2%.
Suspicious masses should be evaluated by US-guided 
vacuum-assisted or core-needle biopsy and they are 
categorized as 4 or 5. Category 4 is subcategorized into 
these levels: 4A, 2%  > to  ≤ 10% likelihood of malignancy; 
4B,  > 10 % to  ≤ 50% likelihood (Figures 1 and 2) and 
4C,  > 50% to  ≤ 95% likelihood (Figure 3). Category 5 
has  ≥ 95% chance of malignancy.20
We reviewed the US images of 78 women with a final 
pathology of IDC under 40 years of age (group A). We 
recorded several US characteristics including margin, 
shape, size, orientation, posterior feature and internal 
echo in SPSS forms.
Then, comparison was made with a control group (group 
B) consisting of 39 patients aged 40 years or more. All the 
patient included had the final diagnosis of IDC NOS type. 
Known BRCA mutations, and other types of breast cancer 
such as medullary carcinoma or mucinous carcinoma 
were excluded. We did not consider the patients’ family 
history of breast cancer in this study.
All statistical analyses were done with the use of the 
SPSS for Windows, version 22.0. In histologic analysis, the 
tumor tissue was fixed, stained, and assessed according 
to the World Health Organization criteria. Tumor grade 
was assessed based on the Nottingham’s grading system 
1–3. We used the chi-square or Fisher’s exact test and non-
parametric tests (Kruskal-Wallis and Mann Whitney test) 
in this research as well as the t-test. P-values of less than 
0.05 were considered statistically significant.
Results
The mean age of the 78 cases was 43.8 years (range 27–78 
y) with SD of 11.3. All of them were women and they had 
masses on the US with a final pathology of IDC NOS. 
None of them had undergone neoadjuvant chemotherapy.
In group A, the mean age was 34.7 ± 3.4 years and in 
group B, it was 51.6 ± 9 old. Overall, the most frequent 
US features of IDC were a mass with indistinct margins 
(43.6%), an irregular shape (55.1%), posterior shadowing 
(38.5%), heterogeneous internal echo (55%), nonparallel 
orientation (59%) and hypoechoic echo pattern (100%). 
Mean size was 15.73 mm (5–36 mm). Details are shown 
in Table 2.
In both groups, non-circumscribed margins were 
Table 1. Ultrasound Descriptors of Malignant Masses vs. Benign Masses16-19 
Ultrasound Descriptors of the Mass Suspicious Appearing/Indeterminate Features of Mass Benign Appearing Features of Mass
Mass shape Round, Irregular Oval
Mass orientation Non parallel Parallel
Mass margin
Non-circumscribed (microlobulated, indistinct, angular, 
spiculated)
Circumscribed
Internal echogenicity Heterogeneous, Isoechoic, Hypoechoic Anechoic, Echogenic
Posterior echo changes Combined, Shadowing, Enhancement No echo change
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Figure 1.  Invasive Ductal Carcinoma. In a 33-year-old woman, the US image shows a hypoechoic mass 
with lobulated shape and indistinct margin with a homogeneous internal echo pattern, posterior 








Figure 2.  Invasive Ductal Carcinoma. In a 32-year-old woman, the US image demonstrates 
heterogeneous mass with round shape, mostly circumscribed margin, posterior enhancement and non-
parallel orientation with final BI-RADS category of 4B.  
 
Figure 1. Invasive Ductal Carcinoma. In a 33-year-old woman, 
the US image shows a hypoechoic mass with lobulated shape 
and indistinct margin with a homogeneous internal echo pattern, 
posterior shadowing and parallel orientation with final BI-RADS 
category of 4A. 
Figure 2. Invasive Ductal Carcinoma. In a 32-year-old woman, the 
US image demonstrates heterogeneous mass with round shape, 
mostly circumscribed margin, posterior enhancement and non-
parallel orientation with final BI-RADS category of 4B. 
 
 
Figure 3. Invasive Ductal Carcinoma. In a 38-year-old woman, the US image reveals a small hypoechoic 
mass with irregular shape and angular margin with a heterogeneous internal echo pattern, no posterior 




Figure 3. Invasive Ductal Carcinoma. In a 38-year-old woman, the 
US image reveals a small hypoechoic mass with irregular shape 
and angular margin with a heterogeneous internal echo pattern, 
no posterior acoustic feature and non-parallel orientation with 
final BI-RADS category of 4C. 
prevalent in 89.7% and 97.4% in groups A and B, 
respectively. The most common mass margin was 
indistinct in both groups, as seen in 41% (16 of 39) in 
group A and in 46.2% (18 of 39) in group B (Table 3). 
In group A, the microlobulated margin was the second 
frequent margin in 30.8% of patients while in group B, this 
rank belonged to the spiculated margin which occurred in 
28.2%, although the difference was not significant. 
In group A the circumscribed margin was much more 
frequent than in group B and it occurred in 10.3% of cases 
while it was found at 2.6% in group B. The least common 
margin in group A was angular but in group B, it was 
circumscribed. All the mentioned differences were not 
statistically significant.
As can be seen in Table 4, there was no significant 
difference between the two groups regarding mass shape 
with a P value of 0.456. Irregularly shaped masses were 
the most common shape found in group A (53.8%) and 
in group B (56.4%). Oval/lobulated masses were more 
prevalent in group A (38%).
Comparing the two groups, the mean diameter of 
the masses at the time of diagnosis was 18.3 mm in the 
younger group and 13.2 mm in the older group, which 
showed a statistically significant difference (P = 0.04). The 
data is presented in Table 5.
There were no significant differences between the age 
groups considering mass boundary, posterior acoustic 
feature, and orientation. 
In the older group (group B), posterior shadowing was 
more prevalent than younger patients (47.8% of cases vs. 
28.2% of cases) but no statistically significant difference 
was detected. On the other hand, posterior shadowing was 
the most common posterior feature in both groups.
Other echo changes in posterior were higher in group A 
than no echo changes and this finding was quite contrary 
to group B; however, no statistically significant differences 
were detected in this case, either. 
In group B, no changes in the posterior feature were 
more prominent (23%) as shown in Table 6.
All the masses were hypoechoic (100%). Most 
of the masses in the older group were hypoechoic 
and homogeneous. In group A, the masses showed 
heterogeneous internal echo (66.7%) unlike group B 
(age  >  40) which mostly exhibited homogeneous internal 
echo with no significant difference (P = 0.07).
As shown in Table 7, we assessed the BI-RADS category 
of the masses in each group. Totally, 79.4% showed BI-
RADS 4 descriptors and 20.5% showed BI-RADS 5.
Among young patients, most showed BI-RADS 4A 
(38%) and there was a significant difference compared to 
the older group (P value of 0.03). The most common BI-
RADS in the latter group was BI-RADS 4B or 5 in group B 
with odds ratio of 2.4 and 95% CI of 0.9–7.2.
Discussion
In 2003, a standardized lexicon for US was developed by 
the American College of Radiology to avoid ambiguity in 
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US images interpretation. The latest edition of BI-RADS 
was published in 2013.20
Whole breast US is being extensively used as an 
adjunctive breast cancer screening method in addition 
to mammography. Various randomized trials (RCTs)21-
23 demonstrate that regular screening mammograms in 
women above the age of 40 can discover breast cancer in 
early stages and reduce fatality by over 30%.1 However, 
in the mammograms of compact and dense breast tissue, 
small underlying masses may be hidden by the tissue. 
Furthermore, the dense breast tissue increases the risk of 
breast cancer independently. Women with dense breast 
composition have a 4–6-fold increased chance of breast 
cancer compared to women with fatty tissue.24-27 Women 
with dense breast tissue who have undergone screening 
mammography may require further assessment, including 
high-resolution US or MRI. Whole breast US is a well-
tolerated, low-priced, convenient, available method of 
screening with no need to use intravenous contrast and no 
radiation. However, it should be done by an expert breast 
radiologist and using the US increases the recall rate and 
screening payment. So, screening US in dense breast tissue 
is challenging.21-27 Previous studies have shown that US 
can find cancers hidden or obscured on mammography, 
especially in women with thick fibroglandular tissue, 
with the same sensitivity of mammography. Additionally, 
previous studies suggest that cancers detected by US 
are small or similar in size and often node-negative in 
comparison with those discovered by mammograms.28
In one study, the sensitivities of mammogram and US 
for cancer detection in dense breasts were 56% and 88%, 
respectively, while they were 80% and 88%, respectively, 
in non-dense breasts.29,30 Thus, US evaluation of breast 
masses would help radiologists to detect suspicious masses 
earlier.
In our study, in young patients, most of malignant masses 
were categorized as BI-RADS 4a (slightly suspicious) 
while in older cases, they were mostly BI-RADS 4b or 
BI-RADS 5. This difference was significant which should 
prompt the breast radiologist to suggest biopsy of slightly 
suspicious masses in younger patients. 
The pseudo-benign appearance in younger patients may 
be due to the lower stromal reaction in the periphery of 
the mass and also higher frequency of aggressive subtypes 
such as hormonal negative and HER2 positive cancers. 
Another point is that in this study, young breast cancer 
Table 2. The Most Common Features of Malignant Masses in Ultrasound in Different Age Groups and in All Patients 
Mass All Patients Under Age 40 Equal/Over Age 40 P Value
Size
Size ≤  20mm (79.5%)
62/78
Size ≤  20mm (71.8%)
28/39
Size ≤  20mm (87.2%)
34/39
0.01

































We used Fisher's exact test and Kruskal-Wallis and Mann Whitney test to analyze the descriptors and obtaining P values.
The frequency and percentage of each ultrasound descriptor are given.




Angular Spiculated Indistinct Microlobulated
Group A 3 (7/6%) 4 (10.2%) 16 (41%) 12 (30.7%) 4 (10.2%) 39
Group B 2 (5.1%) 11 (28.2%) 18 (46.1%) 7 (17.9%) 1 (2.5%) 39
Total 5 (6.4%) 15 (19.2%) 34 (43.5%) 19 (24.3%) 5 (6.4%) 78
Table 4. Frequency of the Different Shapes of the Malignant Masses 





Group A 21(53.8%) 15(38.4%) 3(7.6%) 39
Group B 22(56.4%) 12(30.7%) 5(12.8%) 39
Total 43(55.1%) 27(34.6%) 8(10.2%) 78
Table 5. Frequency of Maximum Size of the Masses in Each Group
Size  ≤  20 mm Size  >  20 mm Total
Group A 28 (71.7%) 11 (28.2%) 39
Group B 34 (87.1%) 5 (12.8%) 39
Total 62 (79.4%) 16 (20.5%) 78
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was larger at the time of diagnosis, which may be due 
to lack of any standard method of screening. A study by 
Wong et al suggested that especially in younger ages, US 
is an important modality of breast cancer screening and is 
associated with more positive findings.30 In addition, we 
suggest that in young females, breast radiologists should 
consider the mass size in the decision for breast core 
needle biopsy, especially in palpable cases. This suggestion 
is similar to a previous study by Kheirelseid et al.31 It 
should also be noted that this finding is mostly consistent 
with previous studies in which most of the young breast 
cancers have demonstrated a palpable nodularity on 
physical exam and they were usually self-detected.15,32-34 
In our study, most malignant masses were non-parallel, 
irregular, indistinct and heterogeneous hypoechoic with 
posterior shadowing. These findings are similar with 
previous studies.15
The margin is an important predictor of whether the 
mass is benign or malignant. Most of the histologically 
diagnosed malignant masses in this research showed non-
circumscribed margin in 93.5% of cases which is similar 
to a study by Bullier et al which reported it at 98.4%.15
Usually, circumscribed masses with sharply defined 
margin are associated with benign entities with a less 
than 2% risk of malignancy. However, in our study, its 
prevalence among masses proven malignant was 9% in 
the young group which is higher than the older group 
(1.2%). It is similar to a previous study conducted by Zhao 
et al in which circumscribed and microlobulated masses 
on mammography were more common among younger 
cases, and estimated at 13.9% in the younger group.35
Regarding margin, there is an additional point that 
the most common mass margin was indistinct which is 
consistent with some previous studies.35
In our research, all the neoplastic masses were 
hypoechoic which is compatible with previous studies.15
Posterior acoustic properties depend on several factors 
such as cellularity, peripheral stromal reaction, and type 
of the adjacent tissue. In this study, the most prevalent 
posterior feature was shadowing in 45% of cases.
In this study, most masses in those aged over 40 years 
had posterior shadowing but in the younger group, the 
number of several types of posterior features were close 
together and shadowing was slightly higher. In previous 
studies, posterior shadowing was seen mostly in 70%–80% 
of cases which is not similar to our study (49% in the older 
group and 36% in the younger group).36
In the evaluation of mass shapes, no statistical 
significance was noted; however, oval-shaped malignant 
masses were frequent in the younger group.
In this study, US characteristics found to be significantly 
associated with younger age breast carcinoma were 
larger size (over 20 mm) and BI-RADS 4A category 
(slightly suspicious US features). These findings may be 
due to delay in diagnosis, the rapid growth of the mass, 
the absence of routine screening method and denser 
fibroglandular tissue.
Our derived results were based on the retrospective 
review of US images. In order to minimize bias, we entered 
all cases with similar pathology (IDC NOS type).
The limitations of this study were the small sample 
size and also the small number of round circumscribed 
malignant masses. 
Further studies with larger sample sizes and new 
epidemiological investigations could prognosticate the 
obligation of screening modalities in this age group.
Being able to predict breast mass pathology by 
evaluation of mass descriptors in different age groups 
would help us to detect cancer characteristics, as we see 
in this research that most of the invasive cancers appeared 
slightly suspicious in these patients.
Notwithstanding the low currency of breast cancer at 
age <40 years, we should consider the risk of malignancy 
in this group, especially in cases with an abnormal clinical 
exam.
Limitation
Our main limitation in this study was the low sample size in this 
single center research, which may be due to the low incidence rate 
of breast cancer in younger ages (about 7%); so, the possibility of 
“sparse-data bias” is present. We hope that multicenter studies 
with large sample sizes could be done in the future.37
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